Showing results (521-530 of 6,499) with videos related to
Sort By:
Pageof 650
Cancer Immunology, Immunotherapy : CII|September 1, 1993
Synergetic effect of interleukin-2 and cellular cytotoxicity against a novel tumor-associated carbohydrate antigen Le(a)/Le(a) (dimeric Le(a)) mediated by monoclonal antibody NCC-ST-421 in adoptive immunization using SCID miceM Watanabe, T Kubota, M Kitajima, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1993
Epitope specificity of the anti-(B cell lymphoma) monoclonal antibody, LL2R Stein, E Belisle, H J Hansen, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
The addition of interleukin-2 to cyclophosphamide therapy can facilitate tumor growth of B16 melanomaT Palomares, P Bilbao, A Alonso-Varona, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
Keyhole limpet hemocyanin contains Gal(beta 1-3)-GalNAc determinants that are cross-reactive with the T antigenI Wirguin, L Suturkova-Milosević, C Briani, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
Potentiation of antitumor effects of tumor necrosis factor alpha and interferon gamma by macrophage-colony-stimulating factor in a MmB16 melanoma model in miceW Lasek, A Wańkowicz, K Kuc, et al.Cancer Immunology, Immunotherapy : CII|May 1, 1995
Pharmacokinetics, tissue distribution, and in vivo antitumor effects of the antimelanoma immunotoxin ZME-geloninK Mujoo, L Cheung, J L Murray, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1995
Functional properties of FC-2.15, a monoclonal antibody that mediates human complement cytotoxicity against breast cancer cellsC Ballaré, M Barrio, P Portela, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1995
Pharmacokinetics of anti-ganglioside GD2 mAb 14G2a in a phase I trial in pediatric cancer patientsM M Uttenreuther-Fischer, C S Huang, R A Reisfeld, et al.Cancer Immunology, Immunotherapy : CII|July 1, 1995
Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrenceM R Young, J Ihm, Y Lozano, et al.Cancer Immunology, Immunotherapy : CII|October 1, 1995
Splenectomy before tumor inoculation prolongs the survival time of cachectic miceK Soda, M Kawakami, S Takagi, et al.Pageof 650